SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-23-002751
Accepted
2023-09-27 00:15:18
Documents
1
Effectiveness Date
2023-09-26
Registration Form
POS AM
Reference AccNo

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 607
  Complete submission text file 9999999995-23-002751.txt   1819
Mailing Address 440 ARMAND-FRAPPIER BLVD. SUITE 300 LAVAL A8 H7V 4B4
Business Address 231 DUNDAS STREET EAST BELLEVILLE A6 K8N 1E2 450-781-0115
Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-251055 | Film No.: 231281721
SIC: 2834 Pharmaceutical Preparations